Cargando…

High-dose chemotherapy in breast cancer: Dutch randomized studies

Detalles Bibliográficos
Autores principales:	Rodenhuis, S, van Tinteren, H, de Vries, EGE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300565/ http://dx.doi.org/10.1186/bcr382

Ejemplares similares

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial
por: Rodenhuis, S, et al.
Publicado: (2005)

High-dose chemotherapy with peripheral blood progenitor cell support in breast cancer: WSG AM01 and MM01
por: Nitz, U, et al.
Publicado: (2001)

On-site audits of the two clinical trials reported from South Africa involving high-dose chemotherapy (HDC) therapy for breast cancer
por: Weiss, RB, et al.
Publicado: (2001)

Molecular subtypes of breast cancer and amplification of topoisomerase IIα: predictive role in dose intensive adjuvant chemotherapy
por: Hannemann, J, et al.
Publicado: (2006)

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients
por: Vollebergh, M. A., et al.
Publicado: (2011)

Pharmacogenetics of FAC chemotherapy side effects in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2015)

The Dutch experience: reciprocal influences between (socio-)political processes and casemix systems
por: van Poucke, Anna
Publicado: (2007)

Predicting breast cancer response to chemotherapy using quantitative magnetic resonance (MR) imaging
por: Turnbull, LW, et al.
Publicado: (2002)

Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy
por: Cedeño, Heidy, et al.
Publicado: (2007)

The use of high-dose azidothymidine in combination with chemotherapy upfront is an effective treatment approach for gamma-herpes virus-related non-Hodgkin’s lymphomas
por: Bayraktar, Ulas Darda, et al.
Publicado: (2010)

Characteristics and first treatment dose of Dutch patients (12-60 years old) receiving prescriptions for asthma and initiating inhaled corticosteroids (ICS) therapy as either extra-fine (EF) ciclesonide or standard-particle (SP)-ICS
por: Van Eickles, Daniela, et al.
Publicado: (2015)

Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy
por: Vollebergh, Marieke A, et al.
Publicado: (2014)

Primary prevention of breast cancer in high-risk women by monitoring epigenetic changes in nipple aspirates
por: van Diest, PJ, et al.
Publicado: (2009)

Partial breast irradiation with interstitial high dose-rate brachytherapy in elderly patients: results of a phase II prospective study
por: Palumbo, Isabella, et al.
Publicado: (2009)

Effect of anthracyclin-based neoadjuvant chemotherapy on disseminated tumor cells in breast cancer patients: an immunocytologic and molecular approach
por: Jäger, CM, et al.
Publicado: (2001)

Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?
por: Steenbruggen, Tessa G, et al.
Publicado: (2015)

An evaluation of the relationship between compressed breast thickness and glandular dose, within the breast screening service
por: Simpson, S
Publicado: (2000)

Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer
por: Ferrucci, PF, et al.
Publicado: (2000)

Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study
por: Westman, G
Publicado: (2000)

Rapid test for detection of high risk of breast cancer
por: Durda, K, et al.
Publicado: (2012)

Individual product determination in the new Dutch DBC system: how to make the system transparent for its users
por: Swiers, R, et al.
Publicado: (2011)

Genetic polymorphisms, efficiency and toxicity of cancer chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Infiltrate analysis of rheumatoid synovial tissue before and after high does chemotherapy and autologous stem cell transplantation
por: Verburg, RJ, et al.
Publicado: (2001)

New diagnostic test for high risk of breast cancer in Poland
por: Gorski, B
Publicado: (2011)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Copper transport system and response to ovarian cancer chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.
por: van der Wall, E., et al.
Publicado: (1996)

High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy
por: de Jonge, M E, et al.
Publicado: (2006)

Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience
por: Schrama, J G, et al.
Publicado: (2003)

High-risk breast cancer patients: comparison of lymphocyte phenotypes and function in vitro
por: Mohrmann, S, et al.
Publicado: (2001)

Effect of high dose remifentanil or sufentanil on postoperative pulmonary function in patients undergoing coronary surgery
por: Eltzschig, HK, et al.
Publicado: (2003)

Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Perceptions of Dutch health care professionals on weight gain during chemotherapy in women with breast cancer
por: de Kruif, J. Th. C. M., et al.
Publicado: (2018)

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study
por: Baas, P, et al.
Publicado: (2006)

High-dose aprotinin reduces systemic inflammatory response syndrome during CABG
por: Tassani, P, et al.
Publicado: (1999)

Chromosome 8q23.3, 10p14 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome – a combined analysis of the Australian, Dutch and Polish Lynch syndrome cohorts
por: Talseth-Palmer, Bente A, et al.
Publicado: (2012)

The relevance of translational research for radiotherapy in breast cancer
por: Bartelink, H
Publicado: (2001)

Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at position 67 to 74 of the HLA-DRB1 molecule
por: de Vries, N, et al.
Publicado: (2002)

Mutation detection in familial and sporadic breast cancers by denaturing high-performance liquid chromatography (DHPLC)
por: Betz, B, et al.
Publicado: (2001)

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
por: Thompson, ER, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ophu39298emr3h465o3r1i2nub